Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)
0.6848
+0.0348
(+5.35%)
Streaming Delayed Price
Updated: 3:27 PM EST, Jan 5, 2026
Add to My Watchlist
All News about Lexaria Bioscience Corp. - Common Stock
Lexaria Attending BIO International Convention
June 05, 2025
Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide
February 20, 2025
Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
February 11, 2025
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
February 06, 2025
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
February 05, 2025
Lexaria Bioscience Earnings Analysis: Q1 Recap ↗
January 10, 2025
Lexaria's Registered GLP-1 Study #4 Begins Dosing
December 19, 2024
Lexaria Forms New Scientific Advisory Board
December 18, 2024
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results ↗
April 25, 2025
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
April 03, 2025
Lexaria's Human GLP-1 Study #5 Begins Dosing
April 02, 2025
Lexaria Releases Annual Letter from the CEO
January 30, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.